ACM
MDGL icon

Aquatic Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Aquatic Capital Management’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-15,032
Closed -$4.64M – 1484
2024
Q4 		$4.64M Buy
+15,032
New +$4.23M 0.13% 213
2023
Q3 		– Sell
-3,600
Closed -$832K – 1487
2023
Q2 		$832K Buy
+3,600
New +$975K 0.05% 344
2022
Q4 		– Sell
-2,300
Closed -$149K – 1632
2022
Q3 		$149K Buy
+2,300
New +$160K 0.01% 676
2022
Q1 		– Sell
-1,100
Closed -$93K – 1332
2021
Q4 		$93K Buy
+1,100
New +$90.4K 0.18% 144

Other funds holding MDGL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return